ACCC

Search Drug Alphabetically

Generic Name	Bicalutamide
Brand Name	Casodex®
Payment Category	Medicare Part D
Year Introduced	1995
Type of Drug	Androgen inhibitor
FDA-Approved Indication(s) Indicated for use in combination with a luteinizing hormone-releasing hormone analog for the treatment of Stage D2 metastatic carcinoma of the prostate. 150 mg daily not approved for use alone or with other agents. (2/27/15)
Approved Indication(s) with Orphan Drug Status	None
ICD-10 Code(s) for Labeled Indication(s)	Malignant neoplasm of prostate [C61]

Name	Strength	Form	Package	Labeler	NDC